Heat Biologics HTBX is working on the Covid-19 vaccine

Heat Biologics HTBX is one of the lowest market cap companies (65.51M) working on the Covid-19 vaccine. It has a lot of room to grow from it`s peak in Oct 4th 2013 (139,90 usd)
The indiccators are also showing a strong buying power.
Heat Biologics Inc. HTBX has previously announced that it is developing a vaccine for the novel coronavirus with the University of Miami Miller School of Medicine. It disclosed March 17 in a financial filing that its COVID-19 vaccine candidate had been added to the World Health Organization’s “draft landscape” of 41 candidate vaccines.
The company also recently joined the Alliance for Biosecurity, which may help it “secure government funding to support its rapid development, production, and distribution” of its COVID-19 vaccine, according to Maxim Group analysts.

Kommentar:

PM me if you want to try the indicators.

Trade geschlossen: Ziel wurde erreicht:

Who listed to this call made 5x his money.